Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation
- 31 March 2004
- journal article
- Published by Elsevier BV in American Heart Journal
- Vol. 147 (3), 463-467
- https://doi.org/10.1016/j.ahj.2003.06.004
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stentingJournal of the American College of Cardiology, 2001
- A randomized, placebo-controlled trial of enoxaparin after high-risk coronary stenting: the ATLAST trialJournal of the American College of Cardiology, 2001
- Antithrombotic Therapy in Patients Undergoing Percutaneous Coronary InterventionSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2001
- Results of the Ticlid or Plavix Post-Stents (TOPPS) trial: do they justify the switch from ticlopidine to clopidogrel after coronary stent placement?Trials, 2000
- Safety and efficacy of ticlopidine for only 2 weeks after successful intracoronary stent placement.Circulation, 1999
- A Clinical Trial Comparing Three Antithrombotic-Drug Regimens after Coronary-Artery StentingThe New England Journal of Medicine, 1998
- Randomized Evaluation of Anticoagulation Versus Antiplatelet Therapy After Coronary Stent Implantation in High-Risk PatientsCirculation, 1998
- Randomized Multicenter Comparison of Conventional Anticoagulation Versus Antiplatelet Therapy in Unplanned and Elective Coronary StentingCirculation, 1998
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996
- A Randomized Comparison of Antiplatelet and Anticoagulant Therapy after the Placement of Coronary-Artery StentsThe New England Journal of Medicine, 1996